Related Experiment Videos
ACE inhibitors or ARBs for diabetic nephropathy: the unrelenting debate
Sunil K Kota1, Lalit K Meher, Sruti Jammula
1Department of Endocrinology, Medwin Hospital, Hyderabad, Andhra Pradesh, India. hidocsunil@ibibo.com
Abstract:
Adequate control of blood pressure is of paramount importance in delaying the progression of renal disease in diabetic patients. Drugs acting on renin angiotensin aldosterone axis are of proven value in diabetes. Particularly angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) have benefits beyond blood pressure control. The current article focuses on various studies supporting the use of ACEIs and ARBs in diabetic subjects.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Diabetic Nephropathy
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Action of Diuretics